Top Banner
hite Matter Lesion Marie Beckner, MD Idiopathic demyelinating disease (MS) described in this module: yelinating diseases, “leukodystrophies ctious demyelination (PML) -infectious demyelination (cross rx to Acquired metabolic demyelination . Toxic leukoencephalopathies
55

White Matter Lesions

Jan 11, 2016

Download

Documents

young young

White Matter Lesions. Marie Beckner, MD. 1. Idiopathic demyelinating disease (MS). 2. Acquired metabolic demyelination. 3. Toxic leukoencephalopathies. Not described in this module: Dysmyelinating diseases, “leukodystrophies” Infectious demyelination (PML) - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: White Matter Lesions

White Matter LesionsMarie Beckner, MD

1. Idiopathic demyelinating disease (MS)

Not described in this module:Dysmyelinating diseases, “leukodystrophies”Infectious demyelination (PML)Post-infectious demyelination (cross rx to Ag)

2. Acquired metabolic demyelination

3. Toxic leukoencephalopathies

Page 2: White Matter Lesions

Primary Demyelination

Damage to oligodendroglia & their myelin sheaths Axons are relatively preserved

Secondary Demyelination

Damaged axon loss of myelin Axonal transectionWallerian degeneration in distal portion

Page 3: White Matter Lesions

1. MULTIPLE SCLEROSIS

First described in 1870’s

Chronic, idiopathic, inflammatorydemyelinating disease of CNS

Selective destrx of oligodendrocytes & myelin with preserved axons

Foci (plaques) widely dispersed in CNS

?Environmental influence acting upon genetically susceptible individuals

Page 4: White Matter Lesions

Multiple Sclerosis

Higher prevalence in colder climates

1 million worldwide, increasing rate

CNS lesions disseminated in space & time

Symptoms: Paresthesias, gait difficulty, weakness/incoordination of 1 or both lower extremities, visual changes

Page 5: White Matter Lesions

MS - Magnetic Resonance Imaging

MRI: T1, T2, FLAIR (fluid-attenuated inversion recovery) New lesions Gadolinium enhancement (recent disruption of blood brain barrier)

Monitoring may help to identify agents that may be active against early inflammatory stage of MS

Page 6: White Matter Lesions

Axial FLAIR

Periventricular hyperintense WM lesions

Hx: 25 yr woman with relapsing- remitting MS

NEJM 343:938-52, 2000

Page 7: White Matter Lesions

9 months later

Axial FLAIR

number & size ofWM lesions

NEJM 343:938-52, 2000

Page 8: White Matter Lesions

With gadolinium

Many lesions demonstrate ring or peripheral enhancement

NEJM 343:938-52, 2000

Page 9: White Matter Lesions

T1-weighted MRIMultiple regionsof diminishedsignal, “blackholes”, in peri-ventricularWM and corpuscallosum. Chronic lesionsof MS.

NEJM 343:938-52, 2000

Page 10: White Matter Lesions

MS - Demyelinated PlaquesWell-demarcated, gray, gelatinous

S. Schochet

Page 11: White Matter Lesions

MS Plaque, often periventricular

Lateral Ventricle

Ellison & Love

Page 12: White Matter Lesions

MS Plaque

Dawson’s fingers?

Extensions alongblood vessels

Rarely see layers ofdemyelinated & morenormally myelinatedwhite matter (not here)

Robbins, 6th ed.

Page 13: White Matter Lesions

Shadow Plaques - partial myelination adjacent to complete demyelination

GRIPE

Page 14: White Matter Lesions

MS Plaque with H&E Stain

Univ. Utah

Page 15: White Matter Lesions

MS Plaque

Luxol FastBlue Stain

Univ. Utah

Page 16: White Matter Lesions

MS Plaque - Luxol Fast Blue Stain

Univ. Utah

Page 17: White Matter Lesions

MS Plaque with Bodian Stain - Axons

Univ. Utah

Page 18: White Matter Lesions

MS Demyelinated PlaquesLoss of myelin (Luxol Fast Blue Stain)

Perivascularlymphocytes

Robbins, 6th ed., 2000

Page 19: White Matter Lesions

MS Demyelinated Plaques

Preservation of axons

Robbins, 6th ed., 2000

Page 20: White Matter Lesions

MS - Perivascular Lymphocytes

Univ. Utah

Page 21: White Matter Lesions

MS-lymphocytes & reactive astrocytes

Univ. Utah

Page 22: White Matter Lesions

MS-lymphocytes & reactive astrocytes

Enlarged, atypical nuclei, not hyperchromatic

Univ. Utah

Page 23: White Matter Lesions

MS Plaque - Subacute - Macrophages

Univ. Utah

Page 24: White Matter Lesions

MS Plaque - Subacute - Macrophages

Gitter cells - myelin breakdown products

Univ. Utah

Page 25: White Matter Lesions

Creutzfeldt cell with minute chromatinfragments

Often found inacute plaques of MS or inastrocytomas.Short-lived dueto cell degen-eration.

NEJM 339:542-9,1998

Page 26: White Matter Lesions

Multiple SclerosisOther locations for plaques?

Optic nerves, brain stem, cerebellum,spinal cord white matter, etc.

What is Devic’s Disease?

Demyelinating lesions of optic nerve(s) & spinal cord (neuromyelitis optica)Clinically, 30-40 yr, acute onset and often rapidly progressive

Page 27: White Matter Lesions

Ellison & Love

Devic’sDisease

Optic Nerve

Page 28: White Matter Lesions

Multiple Sclerosis - TestsCSF: IgG oligoclonal bands or IgG

and lymphocytes (<50 cells)

Abnormal evoked potential studies: central conduction velocities

MRI: Abnormal in 95% patientsGadolinium enhanced lesions 5-10X > than clinical relapses Basis for future clinical trials as an outcome measure

Page 29: White Matter Lesions

MS Clinical CategoriesRelapsing-remitting - episodes of acute worsening w/ recovery & a stable course between relapses

Secondary progressive - gradual neurologic deterioration w/ or w/o superimposed acute relapses in a patient who previously had relapsing-remitting MS

Primary progressive - gradual, nearly continuous neurologic deterioration from the onset of sympt.

Progressive relapsing - gradual neurologic deterioration from the onset of symptoms but with subsequent superimposed relapse

Page 30: White Matter Lesions

MS Variants - Clinical Progression

Charcot type - most common (variable) relapsing-remitting - signs & symptoms w/n days recovery(wks) many develop secondary progression with persistent - signs of CNS dysfunction after relapse - disease may progress between relapses

10% benign MS - do well > 20 years10% primary progressive MS - older patients, chronic progressive myelopathyRare -Progressive relapsing MS

Page 31: White Matter Lesions

Rare MS Variants

Acute MS (Marburg variant) Fulminant, rapid downhill course (fatal w/n months or 1 year) Younger patients Prominent tissue destruction in addition to demyelination CT & MRI lesions may be suspicious due to mass effect & edema and are then biopsied

Page 32: White Matter Lesions

Acute (Marburg-type) MS

Page 33: White Matter Lesions

Rare MS Variants cont...

Bihemispheric widespread demyelinationScattered typical MS plaquesAxonal injury, cavitation, & Wallerian degeneration with sparing of U fibersLeukodystrophy must be excludedDiff. Dx. Of “mental deterioration” in adolescents

Schilder’s Disease (diffuse sclerosis)

Page 34: White Matter Lesions

Rare MS Variants cont...

Balo’s Concentric Sclerosis

Young patientsAcute onset with strokelike symptomsAbsence of remissions & exacerbationsAffected tissue looks layered (onionskin) demyelinated white matter and more myelinated white matter (maybe due to remyelination)

Page 35: White Matter Lesions

Concentric Sclerosis (Balo’s Disease)

Page 36: White Matter Lesions

2. Acquired Metabolic Demyelination

Central pontine myelinolysis (CPM)

Multifocal necrotizing leukoencephalopathy (MNL)

Marchiafava-Bignami disease

Osmotic demyelination syndromes ?

Page 37: White Matter Lesions

Central Pontine Myelinolysis

Rapid serum Na+in hyponatremic patient,(chronic liver dz, alcoholics)Very similar to MS plaque

What is the typical clinical scenario?

Page 38: White Matter Lesions

Central Pontine Myelinolysis

S. Schochet

Page 39: White Matter Lesions

Multifocal Necrotizing Leukoencephalopathy (MNL)

Foci of necrosis with Ca++, WM > GM

Formerly “focal pontine leukoencephalopathy”

Predominantly immunosuppressed patients (AIDS, leukemia, irradiation, amphotericin B, methotrexate, other cytotoxic drugs)

Clinically - complex neurologic abnormalities in patients with long critical illnesses

Page 40: White Matter Lesions

Multifocal Necrotizing Leukoencephalopathy

- ill-defined chalky white foci- distributed in pons and white matter

Ellison and Love, Fig. 22.33, 1998

Page 41: White Matter Lesions

MNL

- spongy vacuolation - swollen axons (may Ca++)- macrophages - foci often microscopic

Page 42: White Matter Lesions

Marchiafava - Bignami Disease

Rare complication of alcoholism

Destruction of myelinated fibersDegeneration of corpus callosum & anterior commissure

Loss of callosal fiberscortical laminar sclerosisMorel’s laminar sclerosis (frontal & temporal cortex, usually layer III)

Page 43: White Matter Lesions

Marchiafava - Bignami Disease

Ellison & Love

Page 44: White Matter Lesions

3. Toxic Leukoencephalopathy

Variability: Diverse mechanisms Target of injury (myelin, astrocytes, blood vessels, etc.)

Etiologies: Cranial irradiation Therapeutic drugs (antineoplastics) Drugs of abuse (cocaine, heroin, ecstasy or MDMA, toluene, etc.) Environmental solvents (organic solvents)

Page 45: White Matter Lesions

Targets of Toxins in Cerebral WM

Filley & Kleinschmidt-DeMasters, NEJM, 2001

Page 46: White Matter Lesions

Toxic Leukoencephalopathies

Clinical: WM tracts for higher cerebral function affected Inattention

Forgetfulness Changes in personality

Dementia Coma Death Absence of aphasia, language preserved

Page 47: White Matter Lesions

Cranial Irradiation

More common for whole brain > local field

Neurobehavioral dysfunction in 28%

3 stages: acute reaction - patchy, reversible WM edema delayed reaction - widespread edema & demyelination severe delayed reaction - loss of myelin and axons due to vascular necrosis and thrombosis

Page 48: White Matter Lesions

Chemotherapy Drugs

Especially those given intrathecallyEspecially when given with irradiationMethotrexate - discrete or confluent necrosis - can cause MNL - vascular lesions in someCarmustineOthers (cisplatin, cytarabrine, fluorouracil, levamisole, fludarabine, thiopeta)Sometimes IL-2, interferon-alpha

Page 49: White Matter Lesions

T2-MRI in man withright frontal GBMafter radiation &chemotherapywith carmustineshowssymmetrichyperintensityof the cerebralwhite matter (2 arrows)

Filley & Kleinschmidt-DeMastsers, NEJM, p.428, 2001

Page 50: White Matter Lesions

Methotrexate Toxicity

6 yrold girl treatedintrathecallyfor leukemia withCNS relapses

Page 51: White Matter Lesions

Methotrexate Toxicity

Swollen axons, many are mineralized

Page 52: White Matter Lesions

TolueneSpray paints, varnishes,thinners, dyes, glues, histology reagents, &aviation fuels

Abused as an inhalant(glue-sniffing)

Myelin degradationT2 MRI in man with dementiaand long-term toluene abuseSymmetric hyperintensity ofWM & ventricular enlargement

Page 53: White Matter Lesions

Ethanol Leukotoxicity

Alcoholics have hyperintense WM foci - MRI

Frontal WM preferentially affected

Fetal alcohol syndrome - delayed myelination & agenesis of the corpus callosum

Marchiafava - Bignami

Atrophy of corpus callosum with necrosis

Dz already discussed?

Page 54: White Matter Lesions

MDMA (“Ecstasy”)

3,4 - methylenedioxymethamphetamine

1999 - 8% U.S. high school seniors

Serotoninergic axonal injury

Oxidative stress damages myelin

Page 55: White Matter Lesions

End of this module

Please send suggestions [email protected]